CLS Global Aggressive Equity Fund (CLACX) is a small-cap equity fund focused on aggressive growth strategies across global markets. The fund primarily invests in high-growth sectors such as technology and healthcare, leveraging a diversified portfolio to capitalize on market inefficiencies.
CLACX generates revenue primarily through management fees based on a percentage of AUM, which can vary depending on the performance of the underlying investments. The fund's aggressive growth strategy allows it to target higher returns, appealing to investors seeking capital appreciation.
Changes in AUM driven by market performance and investor inflows
Performance relative to benchmark indices
Shifts in investor sentiment towards aggressive growth strategies
Regulatory changes impacting asset management fees
Regulatory changes affecting asset management practices
Market volatility impacting investor confidence and inflows
Increased competition from low-cost index funds and ETFs
Pressure on fees due to market saturation
Liquidity risk associated with rapid market downturns
Potential for increased operational costs in a competitive landscape
high - The fund's performance is closely tied to economic cycles, as growth-oriented investments tend to perform better in expanding economies.
Rising interest rates can negatively impact equity valuations, leading to potential declines in AUM and management fees as investors seek safer assets.
minimal
growth - The fund targets investors seeking high capital appreciation through aggressive growth strategies.
high - The fund's focus on aggressive growth sectors typically results in higher volatility.